Search research articles
Contact Us
Filters
Showing results (111-120 of 148) with videos related to
Page
of 15
Sort By:
Nature Medicine
|
October 18, 2025
Perioperative pembrolizumab, trastuzumab and FLOT in HER2-positive localized esophagogastric adenocarcinoma: a phase 2 trial
Alexander Stein, Eray Goekkurt, Salah-Eddin Al-Batran, et al.
Biomedicines
|
December 24, 2021
Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas
Franziska Lea Schümann, Elisabeth Groß, Marcus Bauer, et al.
European Journal of Heart Failure
|
June 30, 2025
Acute dyspnoea in cancer patients: Prevalence of acute heart failure, resource use and diagnostic accuracy of natriuretic peptides
Paolo Bima, Desirée Wussler, Pedro Lopez-Ayala, et al.
Scientific Reports
|
November 1, 2017
Nanobodies effectively modulate the enzymatic activity of CD38 and allow specific imaging of CD38<sup>+</sup> tumors in mouse models in vivo
William Fumey, Julia Koenigsdorf, Valentin Kunick, et al.
British Journal of Cancer
|
May 19, 2026
Differential effects of prior versus concomitant Steroid and Antibiotic Treatment on Immunotherapy Efficacy - A Pooled Analysis of the RAMONA, INTEGA, OPTIM, ELDORANDO, FORCE, TITAN-RCC and TITAN-TCC Trials of the German AIO Study Group
Isabella C Wiest, Lena Dreikhausen, Ralph Keller, et al.
Cancer Research
|
December 30, 2016
Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K<sub>521</sub> Polymorphism
Friederike Braig, Malte Kriegs, Minna Voigtlaender, et al.
Frontiers in Oncology
|
November 1, 2023
Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321)
Joseph Tintelnot, Alexander Stein, Salah-Eddin Al-Batran, et al.
Npj Viruses
|
July 7, 2026
MPXV H3L elicits broadly directed CD4 T cell responses in mpox patients and MVA vaccinees
David da Fonseca Araújo, Christoph Schultheiß, Leon Cords, et al.
Theranostics
|
March 21, 2020
Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignancies
Levin Schriewer, Kerstin Schütze, Katharina Petry, et al.
European Journal of Haematology
|
December 9, 2015
Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemia
Christian Maurer, Natali Pflug, Jasmin Bahlo, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 148) with videos related to
Sort By:
Page
of 15
Nature Medicine
|
October 18, 2025
Perioperative pembrolizumab, trastuzumab and FLOT in HER2-positive localized esophagogastric adenocarcinoma: a phase 2 trial
Alexander Stein, Eray Goekkurt, Salah-Eddin Al-Batran, et al.
Biomedicines
|
December 24, 2021
Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas
Franziska Lea Schümann, Elisabeth Groß, Marcus Bauer, et al.
European Journal of Heart Failure
|
June 30, 2025
Acute dyspnoea in cancer patients: Prevalence of acute heart failure, resource use and diagnostic accuracy of natriuretic peptides
Paolo Bima, Desirée Wussler, Pedro Lopez-Ayala, et al.
Scientific Reports
|
November 1, 2017
Nanobodies effectively modulate the enzymatic activity of CD38 and allow specific imaging of CD38<sup>+</sup> tumors in mouse models in vivo
William Fumey, Julia Koenigsdorf, Valentin Kunick, et al.
British Journal of Cancer
|
May 19, 2026
Differential effects of prior versus concomitant Steroid and Antibiotic Treatment on Immunotherapy Efficacy - A Pooled Analysis of the RAMONA, INTEGA, OPTIM, ELDORANDO, FORCE, TITAN-RCC and TITAN-TCC Trials of the German AIO Study Group
Isabella C Wiest, Lena Dreikhausen, Ralph Keller, et al.
Cancer Research
|
December 30, 2016
Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K<sub>521</sub> Polymorphism
Friederike Braig, Malte Kriegs, Minna Voigtlaender, et al.
Frontiers in Oncology
|
November 1, 2023
Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321)
Joseph Tintelnot, Alexander Stein, Salah-Eddin Al-Batran, et al.
Npj Viruses
|
July 7, 2026
MPXV H3L elicits broadly directed CD4 T cell responses in mpox patients and MVA vaccinees
David da Fonseca Araújo, Christoph Schultheiß, Leon Cords, et al.
Theranostics
|
March 21, 2020
Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignancies
Levin Schriewer, Kerstin Schütze, Katharina Petry, et al.
European Journal of Haematology
|
December 9, 2015
Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemia
Christian Maurer, Natali Pflug, Jasmin Bahlo, et al.
Page
of 15